Exchange: NASDAQ·Updated 06:43 PM EDT
AKTX logo

AKTX Akari Therapeutics

$8.00
$0.24
(3.00%)
Today
Closed $8.24
$0.24
(2.91%)
After Hours
Mkt Cap$14.42M
Vol45,801.00

About AKTX

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company. It engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. The company was founded on October 7, 2004 and is headquartered in Tampa, FL.
45

Neutral Sentiment

How do you feel about AKTX?

dan16
$AKTX i believe the shareholder vote is tomorrow. My almost decade-long hope is that maybe they're waiting to wrap that up before they entertain any deals. If the vote passes, it's very insider and management friendly.
3
BioResearcher
$AKTX Something is brewing ! It could hit $ 50 if partnership is announced ! They just hired Mr. Vatnak Vat-Ho as Chief Business Officer, who has very impressive resume.
1
focafoca99
$AKTX discusses its differentiated PH1 ADC payload strategy and plans Phase 1 for AKTX-101 by mid-2027.
2
BioResearcher
$AKTX It is interesting that this Company keep on filing patents to protect their platform, when they found out more what their drug can do to treat cancers. recently:
1
BioResearcher
$AKTX It is interesting, I asked CharGPT: "when did Akari Therapeutics release data showing it can address ADC resistance issue?"
1
Benny_Cellura
Funny how the trades you almost don't take become the ones you remember. Saw alert, gave it a shot, and ended up +16K$ Definitely waiting on his next Alert, I recommend you follow him💯 $AKTX $KZIA $AGPU rad
focafoca99
$AKTX presents its RNA-splicing ADC payload at the 3rd Annual ADC Payload Summit in Boston on Nov 6.
ABinterceptor
$AKTX Can anyone explain the trajectory of this stock? What are the catalysts? Thank you.
focafoca99
$AKTX amended its CEO agreement, boosting the chief's base salary to $625,000, raising bonus potential and granting RSUs and options.

Advertisement|Remove ads.